Pharmacogenetic Testing for Fluoropyrimidines at Instituto Nacional de Câncer, Brazil

Pharmacogenetic Testing for Fluoropyrimidines at Instituto Nacional de Câncer, Brazil

Saved in:

Bibliographic Details
Main Author:	Guilherme Suarez-Kurtz
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações Ltda. 2025-01-01
Series:	Brazilian Journal of Oncology
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809889
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacogenomic tests of oncology drugs at Instituto Nacional de Câncer (INCA)
by: Guilherme Suarez-Kurtz
Published: (2021-10-01)

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol
by: Ana Hernández-Guío, et al.
Published: (2021-05-01)

Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial
by: Johanne D. Lyhne, et al.
Published: (2025-05-01)

P677: Implementation of pharmacogenomic DPYD-guided fluoropyrimidine dosing for cancer patients in Saskatchewan, Canada
by: Yanwei Xi, et al.
Published: (2025-01-01)

Pharmacogenetic testing: current state of the issue
by: O. V. Kraidashenko, et al.
Published: (2024-11-01)

DPYD Genotyping, Fluoropyrimidine Dosage and Toxicity: An Umbrella Review of Systematic Reviews
by: Sara Otero-Torres, et al.
Published: (2025-05-01)

Cáncer de piel en Colombia: cifras del Instituto Nacional de Cancerología
by: Flavia Carolina Pozzobon, et al.
Published: (2018-04-01)

Pharmacogenetics or predictive genetics? APOE testing blurs the lines
by: Stefania Zampatti, et al.
Published: (2025-07-01)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01)

Population-specific DPYD variants and fluoropyrimidine toxicity risk: an analysis using public genomic databases
by: Suvam Banerjee, et al.
Published: (2025-07-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01)

Irinotecan Plus Mitomycin C as Second-Line Chemotherapy for Advanced Gastric Cancer Resistant to Fluoropyrimidine and Cisplatin: A Retrospective Study
by: Kohei Ogawa, et al.
Published: (2012-01-01)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
by: D. A. Sychev, et al.
Published: (2015-09-01)

Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer
by: Maria Serena Roca, et al.
Published: (2025-08-01)

Alerta de Legislación Nacional del Instituto de Investigaciones Jurídicas
Published: (1981-01-01)

[Comment] Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase Ⅲ OPTICAL trial
by: Zhang Muzi
Published: (2024-06-01)

THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING
by: T. V. Dokukina, et al.
Published: (2016-08-01)

The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01)

Pharmacogenetics of Antiplatelet Drugs
by: Ronan Curtin, et al.
Published: (2002-01-01)

Pharmacogenetics of hypoglycemic agents
by: Irina Vladimirovna Kononenko, et al.
Published: (2015-12-01)

Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01)

Pharmacokinetics and Pharmacogenetics of Dabigatran
by: A. V. Savinova, et al.
Published: (2021-03-01)

Pharmacogenetics of antiretroviral drugs
by: Dragović Gordana, et al.
Published: (2012-01-01)

Pharmacogenetics of chemical addictions
by: E. M. Krupitsky, et al.
Published: (2019-12-01)

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer
by: L. N. Lyubchenko, et al.
Published: (2017-10-01)

Modelo de operación de la biblioteca nacional de ciencia y tecnología del instituto politécnico nacional
by: Noel Ângulo Marcial
Published: (2001-01-01)

The fungal expel of 5-fluorocytosine derived fluoropyrimidines mitigates its antifungal activity and generates a cytotoxic environment.
by: Luis Enrique Sastré-Velásquez, et al.
Published: (2022-12-01)

Da antiga sede da Diretoria Geral de Saúde Pública (DGSP) ao atual Instituto Nacional do Câncer (Inca) From the old headquarters of the Diretoria Geral de Saúde Pública (DGSP) to the Instituto Nacional do Câncer (Inca)
by: Benedito Tadeu de Oliveira
Published: (2007-03-01)

Species of Pieridae (Lepidoptera: Papilionoidea) in the Invertebrate Collection of the Instituto Nacional de Pesquisas da Amazônia (Brazil) with taxonomic updates, specimens photographs, and geographic distributions
by: Gilcélia Melo Lourido, et al.
Published: (2025-03-01)

Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
by: N. A. Shnayder, et al.
Published: (2024-07-01)

El Instituto del Museo de la Universidad Nacional de La Plata
by: Joaquín Frenguelli

Oral probiotic supplementation to alleviate diarrhea induced by fluoropyrimidines or irinotecan-based chemotherapy: A systematic review and meta-analysis
by: Tippawan Siritientong, et al.
Published: (2025-05-01)

Editorial: Pharmacogenetics of psychiatric disorders
by: Sarah Allegra, et al.
Published: (2025-01-01)

Pharmacogenetics of Community-Acquired Pneumonia
by: S. SH. Suleimanov, et al.
Published: (2020-05-01)

De testemunha à protagonista: Beatriz Roquette Bojunga no Instituto Nacional de Cinema Educativo (1936-1965) = From witness to protagonist: Beatriz Roquette Bojunga at the Instituto Nacional de Cinema Educativo (1936-1965) = De testigo a protagonista: Beatriz Roquette Bojunga en el Instituto Nacional de Cinema Educativo (1936-1965)
by: Schvarzman, Sheila
Published: (2021-01-01)

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
by: Grace Shu-wen Chang, et al.
Published: (2020-06-01)

The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress
by: Jennifer M. Finan, et al.
Published: (2024-12-01)

Programa y Reglamento del Instituto de Ciencias Naturales de la Universidad Nacional
by: Dugand Armando, et al.
Published: (1941-11-01)

The Role of Pharmacogenetic-Based Pharmacokinetic Analysis in Precise Breast Cancer Treatment
by: Xinyu Wu, et al.
Published: (2024-10-01)